A Study Of PGN-EDO51 In Participants With Duchene Muscular Dystrophy Amenable To Exon 51-Skipping Treatment

Conditions: Duchenne Muscular Dystrophy Interventions: Drug: PGN-EDO51 Sponsors: PepGen Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials